focus -WSS

focus

author：focus 2025-10-01 04:09:55 - browse：4238

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Scientists unlock the key to scar

focus

WSS

Why getting cancer drugs just got harder for rural patients

Menendez indictment could see pharma lose a key ally

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Why do women spend more than men on medical expenses?

Medicare drug price negotiation program allowed for now

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

explore

Medicare details structure of new drug price negotiation program

How one patient went off dialysis — and others can too

The high cost of giving birth even with insurance

Medical device lobby: We're tired of waiting on Medicare coverage

ChatGPT in medicine: STAT answers readers' burning questions

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Affirmative action in medical school literally saved lives

Kenai launches with $82 million for Parkinson’s stem cell therapy

How to save PrEP access — and even expand it

Kaiser Permanente unions announce official strike date

hotspot

Data show record exodus of life scientists from academia

Shingles, which affected Dianne Feinstein, is on the rise

Researchers use wearables data and AI to predict preterm birth risk

FDA does about

RaDonda Vaught to speak at CommonSpirit event on patient safety

Paxlovid should be available without a positive Covid test

focus

focus

leisure time

knowledge